u/coring_the_stopper

I would not post that as a finding. It is a single result and the template asks you to say so.

How long has it been sitting, and at which stage?

I would be careful here. "Everyone gets this" is not true, and it makes the people who get something unusual assume they are fine when they should be asking.

Came off sema and onto tirz with a two-week gap. The first month was flat and I assumed I had made a mistake. Month two it moved.

Fourth lot from the same supplier in the log now and the band has been tight the whole way. That consistency is the actual finding.

reflux at night, try not eating in the three hours before bed

New plan year, entirely new criteria, and the denial that had been immovable in the autumn simply did not apply in January.

Two years and four months on a tier 3 list. Referral date and every letter kept, which turned out to matter when the service reorganised.

Are you eating in the couple of hours before you sleep?

Has a peer-to-peer been offered or requested?

a template letter that quotes their own criteria back is the strongest one

A peer-to-peer conversation puts the prescribing clinician in front of a reviewing clinician. It bypasses the correspondence cycle entirely and is often the fastest available route.

Switching from semaglutide, since three people asked in this thread alone.

There is no published dose equivalence between the two. The conversion tables that circulate are somebody’s arithmetic, not data. What people report here is that the first month after a switch is often flat, that the appetite effect feels differently shaped rather than simply stronger, and that starting at the bottom of the ladder again is the common approach.

None of that is a recommendation. It is what the threads say, and the threads are not a clinic.

Right, and the hair thing is worth repeating: it tracks the rate of loss rather than the compound, and it stops.

Careful — the deadline runs from the date on the letter. Waiting for a call back can cost you the appeal entirely.

Area percent and net peptide content are different measurements and most reports give one. Quote which, or the comparison downstream is meaningless.

How many separate lots does your series cover?

That percentage is body weight change, not body fat. Different measurement, and the distinction gets lost every time.

the four-week step schedule is the label, not folklore

Agreed on quoting the claim alongside the result. Half the arguments here are two people comparing to different reference numbers.

How to build a series that means something, if you are going to spend money on testing anyway.

Three tests on one lot tells you about your measurement. Three tests on three lots, spread over a year, tells you about a process. The second is the one worth paying for and it costs the same.

Buy small, keep the batch numbers, send one vial per lot, and post each one with the claim next to it. After four or five you have something no individual review can give you: a band, a direction and a date range. That is what the source pages are made of.

The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.

zepbound and mounjaro are the same compound with different labels

Switching from semaglutide, since three people asked in this thread alone.

There is no published dose equivalence between the two. The conversion tables that circulate are somebody’s arithmetic, not data. What people report here is that the first month after a switch is often flat, that the appetite effect feels differently shaped rather than simply stronger, and that starting at the bottom of the ladder again is the common approach.

None of that is a recommendation. It is what the threads say, and the threads are not a clinic.

What is intake actually looking like — fibre and water especially?

regional stock removes the question entirely

Nobody warned me about muscle cramps and I would have liked the warning. It was not dangerous, it was just deeply unpleasant and completely unexpected.

Which nation, and which ICB if you are in England?

the food noise going quiet is the effect people came for, and sulphur burps are the toll for the first fortnight

Agreed on keeping letters. Dates are what make an appeal or a re-referral possible.

I would be careful here. "Everyone gets this" is not true, and it makes the people who get something unusual assume they are fine when they should be asking.

split a vial across two services once and you will never argue about ground truth again

What is the waist doing? That is usually the number still moving during a scale stall.